Edmonton-based biotech 48Hour Discovery is invited to travel to Pangyo Technoo Valley, the Korean version of the Silicon Valley, to expand their technology into the Asian market EDMONTON, ALBERTA (August 13, 2020) – A biotechnology startup partner of GlycoNet is...

A University of Alberta spinoff company is adding their cutting-edge technology to the search for antiviral compounds to treat individuals infected with COVID-19. 48Hour Discovery was founded by Ratmir Derda, associate professor in the Department of Chemistry, in 2017....

48Hour Discovery Inc. announced today that it has initiated drug discovery projects for therapeutic targets related to COVID-19. 48Hour Discovery Inc. is using its proprietary technology to rapidly develop peptide-based anti-viral compounds for treatment of those infected with COVID-19. The company...

New technology platform would deliver orally available small molecule therapeutics for a wide range of targets EDMONTON, ALBERTA (April 18, 2019) – 48Hour Discovery (48HD) today announced that it will  receive up to $193,000 from the National Research Council of Canada...

Collaboration receives $300,000 CAD grant to further develop and commercialize TumorGenesis oncology discovery technologies MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) – Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced that its wholly owned subsidiary, TumorGenesis, is participating with 48Hour Discovery (48HD),...

EDMONTON, ALBERTA (April 15, 2019) – 48Hour Discovery INC., a biotechnology company focused on the discovery of peptide-derived small molecule therapeutics, is pleased to welcome Dr. John Dwyer as its new Vice President of Research. This is a key step in...

EDMONTON, ALBERTA (March 11, 2019) – 48Hour Discovery Inc. announced the appointment of David Alton as the Director of Business Development, effective March 11, 2019. Alton will bring extensive experience in leadership to the management team, strengthen the Company’s business...

EDMONTON (April 17 2018)–48Hour Discovery Inc. (48HD) is pleased to announce a sponsorship with the Canadian Glycomics Network (GlycoNet) to support the Canadian Glycomics Symposium 2018. The Symposium affords an exciting opportunity to glimpse the frontiers of knowledge in...

Join us for an exclusive tour of our molecular discovery platform. This half day workshop will take you through our exciting new technology and will involve hands-on experiments and real-time data analysis. The workshop will describe how you can leverage our...

Edmonton-based start-up to develop personalized cancer therapy models: EDMONTON (March 29, 2018)–48Hour Discovery Inc. (48HD) announced today that they have signed an agreement with Precision Therapeutics Inc. (NASDAQ:AIPT) and its wholly owned subsidiary, TumorGenesis Inc. 48HD will grant access...